Add BrightSurf on Google Email

Are covid ‘comas’ signs of a protective hibernation state?

Researchers at MIT's Picower Institute suggest that Covid-19 patients in comas may enter a protective hibernation state to shield cells from oxygen scarcity. This hypothesis is supported by observations of cardiac arrest patients treated with hypothermia and the painted turtle, which also enters a similar state during prolonged anoxia.

SourcePicower Institute at MIT·JournalProceedings of the National Academy of Sciences·TypeLiterature review·DateNov 7, 2022

Speaking your mind: patients' speech can reveal type of dementia

A study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring found that analyzing patients' speech can distinguish between different types of dementia. The research team developed a machine learning model using speech features to identify Alzheimer's disease and Lewy body dementia.

SourceUniversity of Tsukuba·JournalAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·DateNov 3, 2022

Mapping the path from smell to perception

Scientists have created an extensive new map of the brain's olfactory circuits, revealing a complex system that processes different aspects of odor information. The map suggests the existence of parallel neural circuits dedicated to assessing smell identity, pleasantness, and origin, offering new insights into olfactory processing.

Large stroke trial finds intensive blood pressure lowering after clot removal worsens recovery

A large stroke trial found that intensive blood pressure lowering after clot removal compromises the return of blood flow to the affected area, leading to more brain tissue deterioration and major disability. The study suggests that this increasingly common treatment strategy should be avoided in clinical practice.

SourceGeorge Institute for Global Health·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateOct 28, 2022

Pressure chamber therapy has been found to be effective in the functional improvement of autism

A Tel Aviv University study shows that pressure chamber therapy can improve social skills and reduce neuroinflammation in the autistic brain. The treatment, which involves high-pressure chambers with oxygen enrichment, was found to increase blood and oxygen supply to the brain, leading to improved brain function and social behavior.

SourceTel-Aviv University·JournalInternational Journal of Molecular Sciences·DateOct 26, 2022

Small-molecule drug reverses neural effects of concussion

Researchers at UCSF discovered a small molecule called ISRIB that can reverse the neural and cognitive effects of concussion in mice, weeks after an injury occurred. The drug blocks the integrated stress response, which became chronically activated in damaged neurons, restoring normal spine dynamics and cognitive function.

SourceUniversity of California - San Francisco·JournalProceedings of the National Academy of Sciences·DateOct 10, 2022

Video games offer the potential of “experiential medicine”

Scientists at UC San Francisco's Neuroscape Center have developed video game interventions that improve key aspects of cognition in aging adults, including short-term memory, attention and long-term memory. The games use adaptive closed-loop algorithms to challenge players, keeping them engaged while adapting difficulty levels.

SourceUniversity of California - San Francisco·JournalProceedings of the National Academy of Sciences·DateOct 3, 2022

National Institutes of Health Awards Cleveland Clinic $10.7 Million to expand national consortium studying Dementia with Lewy Bodies

The National Institutes of Health has awarded a $10.7 million grant to Cleveland Clinic to expand a national research consortium focused on improving diagnosis and treatments for Dementia with Lewy Bodies. The consortium, which includes multiple clinical sites, aims to identify biomarkers for disease and develop new therapies.

Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke

A new study found that the newer clot-busting drug tenecteplase outperforms traditional treatment for ischemic strokes in several key areas, including better health outcomes and lower costs. The shorter preparation and injection time with tenecteplase eliminated dosing errors and initiated transfers to advanced care sooner.

New research throws doubt on old ideas of how hearing works

A study by researchers at Linköping University and the Oregon Health and Science University has discovered that many cells in the inner ear react simultaneously to low-frequency sound, making it easier to experience these sounds. This new understanding may lead to improved cochlear implants for people with severe hearing impairments.

SourceLinköping University·JournalScience Advances·TypeExperimental study·DateSep 23, 2022

Molecular changes in the brain in the aftermath of a traumatic event may help explain long-term susceptibility or resilience

Researchers found that stressed mice exhibited decreased neuron excitability in the dorsal hippocampus, which may drive social avoidance, while resilient mice showed increased excitability. This difference was linked to changes in stress hormone receptors and HCN1 protein expression.

SourceMedical College of Georgia at Augusta University·JournalMolecular Psychiatry·DateSep 20, 2022

Neurologic complications of smallpox, monkeypox

This review examines the known neurologic complications of smallpox and monkeypox, including their complications from vaccination. The study highlights the importance of understanding these neurological effects to improve treatment and prevention strategies.

SourceJAMA Network·JournalJAMA Neurology·DateSep 20, 2022

Cooling away the pain: Pusan National University researchers develop bioresorbable, implantable device to block pain signals from peripheral nerves

Scientists have developed a soft, bioresorbable device that cools peripheral nerves to reduce pain. The device was tested in rat models and found to be effective, reversible, and non-addictive, with potential applications for treating neuropathic pain after surgery.

SourcePusan National University·JournalScience·TypeExperimental study·DateSep 6, 2022

High cholesterol, overweight and reduced physical stamina are long COVID sequelae in young adults

A new study found that young Swiss military personnel with confirmed Covid-19 infections experienced symptoms like fatigue, reduced sense of smell, and psychological problems for up to 180 days. Long-term effects included increased BMI, high cholesterol, and lower physical stamina, suggesting a higher risk of metabolic disorders and ca...

SourceUniversity of Zurich·JournalThe Lancet Infectious Diseases·TypeData/statistical analysis·DateSep 5, 2022

SPIE journal Neurophotonics publishes comprehensive status report on optical imaging methods for brain science

The report explores diffuse optical imaging methods applicable to noninvasive human studies, including near-infrared spectroscopy (NIRS) and diffuse correlation spectroscopy (DCS). It introduces state-of-the-art technologies and software, exploring their impact on neuroscience and clinical applications.

Early blood tests predict death, severe disability for traumatic brain injury

Researchers developed a blood test that predicts poor outcomes in patients with traumatic brain injury (TBI), allowing clinicians to make decisions earlier on possible treatment. The test, which measures protein biomarkers GFAP and UCH-L1, showed high accuracy in predicting death and severe disability six months after injury.

SourceMichigan Medicine - University of Michigan·JournalThe Lancet Neurology·TypeRandomized controlled/clinical trial·DateAug 19, 2022

Prenatal opioid exposure may trigger neurological, behavioral changes later in life

A new study at the University of Missouri found that prenatal opioid exposure can trigger long-term neurological or behavioral effects in children. The research suggests that opioids impact the developing fetus' gut microbiome, leading to changes in metabolic pathways and potentially affecting overall health and wellness.

SourceUniversity of Missouri-Columbia·JournalmSystems·TypeExperimental study·DateJul 29, 2022

Fewer relapses in MS with off-label drug

A phase 3 clinical trial found that patients with relapsing-remitting multiple sclerosis treated with rituximab had a five-fold lower risk of relapse compared to those receiving standard dimethyl fumarate treatment. Rituximab also showed fewer new MS plaques on magnetic resonance imaging.

SourceKarolinska Institutet·JournalThe Lancet Neurology·TypeRandomized controlled/clinical trial·DateJul 13, 2022

UCalgary researchers with the Calgary Stroke Program make another breakthrough in the treatment of stroke

Researchers with the Calgary Stroke Program have made a breakthrough in treating acute ischemic stroke with Tenectepele, a safe and well-tolerated drug that can be administered as a single dose. The study shows that TNK works better than current recommended drug tPA, restoring blood flow faster and for a longer period.

SourceUniversity of Calgary·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateJun 29, 2022

Bodychecking experience does not lower risk of injury for teen hockey players

A new study published in CMAJ found that youth hockey players with more years of bodychecking experience had a significantly higher risk of concussion than those with less experience. The researchers collected data on 941 players aged 15-17 and found that concussion was the most common injury, making up over one-third of all injuries.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateJun 20, 2022

COVID-19 on the brain: Neurological symptoms persist in majority of long-haulers

A UC San Diego longitudinal study found that most COVID-19 long-haulers continue to suffer from neurological symptoms six months after infection, with memory impairment and decreased concentration being the most prevalent. Researchers identified a new subgroup with advanced symptoms, including tremor and difficulty balancing.

SourceUniversity of California - San Diego·JournalAnnals of Clinical and Translational Neurology·DateJun 15, 2022

Drumming improves behaviour and brain function in autistic adolescents, scientists reveal

A new study reveals that drumming can improve the life quality of young people diagnosed with autism by enhancing brain function and behavior. Participants showed fewer signs of hyperactivity, inattention, and repetitive behaviors, demonstrating better control of their emotions.

SourceUniversity of Chichester·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateJun 10, 2022